大肠直肠癌中的HOTAIR:结构,功能和治疗潜力
1Institute of Biomedical Sciences, Shanxi University, Taiyuan, 030006, China. mtufail0276@gmail.com.
Medical oncology (Northwood, London, England)
|August 2, 2023
概括
长非编码RNAHOTAIR在结直肠癌 (CRC) 中被上调,促进瘤生长和治疗耐药性. 了解一个HOTAIR
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 长非编码RNAs (lncRNAs) 是癌症中基因表达的关键调节者.
- 该lncRNAHOTAIR涉及各种细胞过程和癌症的发展.
- 过度表达HOTAIR与结直肠癌 (CRC) 的预后不佳和化疗抵抗有关.
研究的目的:
- 阐明HOTAIR在结直肠癌中的结构,功能和机制.
- 探索HOTAIR在CRC中基因调节和治疗耐药性的作用.
- 确定HOTAIR作为结直肠癌的潜在治疗点.
主要方法:
- 在CRC中对HOTAIR现有文献的审查.
- 对HOTAIR分子结构和域相互作用的分析.
- 研究HOTAIR与miRNA和蛋白质复合物的调控相互作用.
主要成果:
- 在CRC组织中,HOTAIR表达显著上调.
- 霍泰尔通过染色体重塑和基因沉默促进CRC进展.
- 霍泰尔与特定的微RNA (miRNA) 相互作用,调节基因表达.
- 霍泰尔有助于结直肠癌中的化学抵抗.
结论:
- 霍泰尔是结肠直肠癌中的一个关键的致癌性 lncRNA.
- 向HOTAIR为CRC提供了一个有前途的治疗策略.
- 需要进一步的研究才能充分理解HOTAIR在CRC和耐药性方面的机制.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K


